||Recombinant Human BMP10 (Accession # O95393), fused with , was produced in Mouse myeloma cell line, NS0-derived.
|Predicted N Terminal:
||Ser20 & Pro23
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by its ability to inhibit BMP-10-induced alkaline phosphatase production by MC3T3-E1 mouse preosteoblast cells.The ED50 for this effect is typically 0.75 - 3 µg/mL in the presence of 100 ng/mL of rhBMP-10.
||Recombinant Human BMP10 has a calculated MW of 34.6 kDa. In SDS-PAGE migrates as 42-50 kDa, reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).